Avadel Pharmaceuticals PLC (AVDL) financials · rev $169.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Avadel Pharmaceuticals PLC (AVDL) rev $169.1M.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $169.1M | $28.0M |
| Cost of Revenue | $15.3M | $846.0K |
| Gross Profit | $153.8M | $27.1M |
| Operating Income | -$42.4M | -$137.8M |
| Net Income | -$48.8M | -$160.3M |
| EPS (Diluted) | -$0.51 | -$2.00 |
| Line | FY2024 | FY2023 |
|---|---|---|
| Total Assets | $164.2M | $164.7M |
| Current Assets | $134.2M | $134.2M |
| Cash & Equivalents | $51.4M | $31.2M |
| Inventory | $20.3M | $10.4M |
| PP&E | $453.0K | $585.0K |
| Total Liabilities | $90.4M | $77.0M |
| Current Liabilities | $48.8M | $36.9M |
| Shareholders' Equity | $73.8M | $87.7M |
| Retained Earnings | -$794.3M | -$745.5M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$46.9M | -$128.5M |
| CapEx | N/A | N/A |
| Investing Cash Flow | $51.8M | -$50.1M |
| Financing Cash Flow | $16.0M | $135.3M |
| Net Change in Cash | $20.2M | -$42.8M |
| Free Cash Flow | -$46.9M | -$128.5M |
FAQ
What is AVDL P/E and revenue?
Avadel Pharmaceuticals PLC (AVDL) rev $169.1M.
What is AVDL revenue?
Avadel Pharmaceuticals PLC last cached revenue is $169.1M (FY2024).
Is AVDL profitable?
Avadel Pharmaceuticals PLC last cached net income is -$48.8M (FY2024).
What are AVDL total assets?
Avadel Pharmaceuticals PLC last cached total assets are $164.2M (FY2024).
What is AVDL free cash flow?
Avadel Pharmaceuticals PLC last cached free cash flow is -$46.9M (FY2024).
Not investment advice. Cached statements, not a live tape.